Alcobra Ltd. to Release First Quarter 2015 Financial Results and Host Corporate Update Conference Call & Webcast on May 6
16 avr. 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, April 16, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at Two CNS Focused Conferences in April
06 avr. 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, April 6, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra's MDX Meets Primary Endpoint in Phase II Safety and Tolerability Clinical Trial in Adolescents With ADHD
10 mars 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, March 10, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at 27th Annual ROTH Conference
03 mars 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, March 3, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Fourth Quarter and Fiscal Year 2014 Financial Results and Provides Corporate Update
12 févr. 2015 07h30 HE
|
Alcobra Ltd.
Conference Call & Webcast at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
TEL AVIV, Israel, Feb. 12, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical...
Alcobra Ltd. to Release Fourth Quarter and Fiscal Year 2014 Financial Results and Host Corporate Update Conference Call & Webcast on February 12
02 févr. 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Feb. 2, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at BIO CEO & Investor Conference
29 janv. 2015 08h11 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option
14 janv. 2015 09h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Jan. 14, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) today reported that it has closed its previously announced public offering of ordinary shares. The Company sold 7,475,000...
Alcobra Ltd. Prices Public Offering of Ordinary Shares
09 janv. 2015 09h06 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Jan. 9, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) announced the pricing of its previously announced underwritten public offering of 6,500,000 ordinary shares at an offering...
Alcobra Ltd. Announces Commencement of Public Offering of Ordinary Shares
08 janv. 2015 16h19 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Jan. 8, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) announced today that it intends to offer its ordinary shares in an underwritten public offering. The offering is subject...